Webinar: Latest Treatment Advances for Dementia & Alzheimer’s Disease

You are invited to join Paul Schulz, MD, for a previously recorded live educational webinar on the latest treatment advances for dementia and Alzheimer’s disease.

Dr. Schulz is a professor and Director of the Memory Disorders and Dementia Clinic in the Department of Neurology at McGovern Medical School at UTHealth Houston. He is fellowship trained in cellular neurophysiology.

A UTHealth Neurosciences physician affiliated with Mischer Neuroscience Institute, he is currently investigating risk factors for dementia and is utilizing Aduhelm™ (aducanumab-avwa), the promising new treatment option for Alzheimer’s disease, in his patients’ treatment plans, when appropriate.

Dr. Schulz will discuss Aduhelm™, the newest Alzheimer’s disease drug in over 20 years.

During the webinar, you will learn more about:

• What are dementia and Alzheimer’s disease
• Signs and symptoms of dementia and Alzheimer’s disease, and how to know the difference
• New treatment option Aduhelm™ —the first FDA -approved drug that affects the course of Alzheimer’s disease

During the webinar, you will get answers relating to:

• Other approaches to treating Alzheimer’s disease
• Insurance coverage for testing
• Qualifications for this new medication

For Physicians: Refer a patient here »